AZTR

Azitra (AZTR)

Azitra Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AZTR

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/27	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AZTR	Azitra Inc
2024/11/13	07 : 05	PR Newswire (US)	Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates	AMEX:AZTR	Azitra Inc
2024/11/13	07 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:AZTR	Azitra Inc
2024/10/29	22 : 00	Business Wire	Azitra to Present at BIO-Europe 2024	AMEX:AZTR	Azitra Inc
2024/10/11	22 : 00	Business Wire	Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit	AMEX:AZTR	Azitra Inc
2024/10/10	06 : 01	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	AMEX:AZTR	Azitra Inc
2024/10/10	05 : 55	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:AZTR	Azitra Inc
2024/09/24	21 : 00	Business Wire	Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress	AMEX:AZTR	Azitra Inc
2024/09/18	22 : 00	Business Wire	Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors	AMEX:AZTR	Azitra Inc
2024/09/17	06 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	AMEX:AZTR	Azitra Inc
2024/09/07	05 : 30	Business Wire	Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference	AMEX:AZTR	Azitra Inc
2024/08/28	21 : 30	Business Wire	Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome	AMEX:AZTR	Azitra Inc
2024/08/22	22 : 00	Business Wire	Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors	AMEX:AZTR	Azitra Inc
2024/08/21	05 : 15	Business Wire	Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome	AMEX:AZTR	Azitra Inc
2024/08/13	07 : 23	Business Wire	Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates	AMEX:AZTR	Azitra Inc
2024/08/13	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AZTR	Azitra Inc
2024/08/13	06 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:AZTR	Azitra Inc
2024/08/03	05 : 05	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	AMEX:AZTR	Azitra Inc
2024/07/30	05 : 01	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	AMEX:AZTR	Azitra Inc
2024/07/27	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:AZTR	Azitra Inc
2024/07/26	06 : 57	Business Wire	CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering	AMEX:AZTR	Azitra Inc
2024/07/26	03 : 15	Business Wire	Azitra, Inc. Announces Closing of Public Offering	AMEX:AZTR	Azitra Inc
2024/07/25	19 : 03	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:AZTR	Azitra Inc
2024/07/24	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:AZTR	Azitra Inc
2024/07/24	10 : 20	Business Wire	Azitra, Inc. Announces Pricing of $10.0 Million Public Offering	AMEX:AZTR	Azitra Inc
2024/07/23	21 : 00	Business Wire	Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents	AMEX:AZTR	Azitra Inc
2024/07/20	06 : 27	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	AMEX:AZTR	Azitra Inc
2024/07/16	06 : 11	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	AMEX:AZTR	Azitra Inc
2024/07/15	19 : 21	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	AMEX:AZTR	Azitra Inc
2024/07/09	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:AZTR	Azitra Inc